These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725 [TBL] [Abstract][Full Text] [Related]
12. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473 [TBL] [Abstract][Full Text] [Related]
14. An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice. Do A; Reid RC; Lohman RJ; Sweet MJ; Fairlie DP; Iyer A J Pharmacol Exp Ther; 2017 Jan; 360(1):140-151. PubMed ID: 27827303 [TBL] [Abstract][Full Text] [Related]
15. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis. Lenzen H; Qian J; Manns MP; Seidler U; Jörns A J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942 [TBL] [Abstract][Full Text] [Related]
16. Porcine β-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. Han F; Zhang H; Xia X; Xiong H; Song D; Zong X; Wang Y J Immunol; 2015 Feb; 194(4):1882-93. PubMed ID: 25601921 [TBL] [Abstract][Full Text] [Related]
17. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis. Darsigny M; St-Jean S; Boudreau F Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487 [TBL] [Abstract][Full Text] [Related]
18. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. Andres PG; Beck PL; Mizoguchi E; Mizoguchi A; Bhan AK; Dawson T; Kuziel WA; Maeda N; MacDermott RP; Podolsky DK; Reinecker HC J Immunol; 2000 Jun; 164(12):6303-12. PubMed ID: 10843684 [TBL] [Abstract][Full Text] [Related]